Rutherford well placed to accelerate growth after 30% jump in revenue

Cancer treatment specialist Rutherford Health has said it is well positioned to drive meaningful growth in the short to medium term after booking a 30% jump in revenue to £7.3m for the year ended 28 February 2021. CEO Mike Moran said the Covid-19 pandemic had tested the company’s resilience and demonstrated the underlying strength of…

You must be a HM Subscriber to view this content.

Subscribe Now »